EMEA-000332-PIP02-17-M01

Key facts

Invented name
Briviact (in Italy: Nubriveo)
Active substance
Brivaracetam
Therapeutic area
Neurology
Decision number
P/0203/2020
PIP number
EMEA-000332-PIP02-17-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of paediatric epilepsy syndromes
Route(s) of administration
Oral use
Contact for public enquiries
UCB Pharma S.A.

Tel. + 353 14632371
E-mail: ucbcares.ie@ucb.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings